Dr. Santini leads the MDS program in the Hematology Unit at the Azienda Ospedaliero Universitaria Careggi Medical School, University of Florence. She was recognized for her scientific interests and publications focused on maturation induction and therapeutic targeting of epigenetics modifications, myeloid leukemias, and myelodysplastic syndromes (MDS).
A member of the AAMDSIF Medical Advisory Board, Dr. Santini is also a member of the European Society of Hematology (EHA), the Scientific Committee of the European School of Hematology (ESH), and the American Society of Hematology. She has been an invited speaker at numerous international meetings including the European Hematology Association, American Society of Clinical Oncology, American Society of Hematology, the AAMDSIF International Scientific Symposium and national hematology societies of several countries (Spain, France, Argentina, Brazil, Poland, Thailand, Lebanon, Slovenia).
Dr. Santini has served for two terms on the executive board of the Italian Society of Haematology and she has been Vice-president of the Italian Society of Experimental Haematology and Vice President of the Fondazione Italiana Sindromi Mielodisplastiche (FISM). She is also an author of more than 140 peer-reviewed papers published in international journals.